Renal Insufficiency  >>  emapticap pegol (NOX E36)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emapticap pegol (NOX E36) / TME Pharma
NCT01372124: A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36

Completed
1
32
Europe, RoW
NOX-E36
TME Pharma AG
Renal Impairment
10/12
10/12

Download Options